CO6761367A2 - Inactivación viral usando un método mejorado de solvente -detergente - Google Patents

Inactivación viral usando un método mejorado de solvente -detergente

Info

Publication number
CO6761367A2
CO6761367A2 CO13165222A CO13165222A CO6761367A2 CO 6761367 A2 CO6761367 A2 CO 6761367A2 CO 13165222 A CO13165222 A CO 13165222A CO 13165222 A CO13165222 A CO 13165222A CO 6761367 A2 CO6761367 A2 CO 6761367A2
Authority
CO
Colombia
Prior art keywords
viral inactivation
improved solvent
detergent method
virus
detergent
Prior art date
Application number
CO13165222A
Other languages
English (en)
Inventor
Martin Felgenhauer
Dominique Mison
Frederic Montandon
Maria Farcet
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of CO6761367A2 publication Critical patent/CO6761367A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

El presente capítulo descriptivo divulga métodos de inactivar un virus que contiene una cubierta lipídica y proteínas esencialmente libres de un virus que contiene una cubierta lipídica, obtenidas de tales métodos.
CO13165222A 2010-12-15 2013-07-11 Inactivación viral usando un método mejorado de solvente -detergente CO6761367A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42351210P 2010-12-15 2010-12-15

Publications (1)

Publication Number Publication Date
CO6761367A2 true CO6761367A2 (es) 2013-09-30

Family

ID=45476616

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13165222A CO6761367A2 (es) 2010-12-15 2013-07-11 Inactivación viral usando un método mejorado de solvente -detergente

Country Status (18)

Country Link
US (2) US20120208982A1 (es)
EP (2) EP3495385A1 (es)
JP (1) JP6013360B2 (es)
KR (2) KR101854310B1 (es)
CN (2) CN103370072B (es)
AR (1) AR084301A1 (es)
AU (1) AU2011343811B2 (es)
BR (1) BR112013015113B1 (es)
CA (1) CA2821971A1 (es)
CO (1) CO6761367A2 (es)
EA (1) EA025783B1 (es)
IL (1) IL226926B (es)
MX (1) MX352082B (es)
MY (1) MY161252A (es)
NZ (1) NZ611994A (es)
SG (2) SG10201509994PA (es)
TW (1) TWI557229B (es)
WO (1) WO2012082931A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2879691T3 (da) * 2012-08-06 2019-06-11 Biogen Ma Inc Fremgangsmåder og sammensætninger til inaktivering af kappebærende vira
TWI641382B (zh) * 2013-01-31 2018-11-21 韓美藥品股份有限公司 於包含因子ｖｉｉ之組成物中使病毒失活之方法
KR102238133B1 (ko) * 2013-11-15 2021-04-09 제넨테크, 인크. 환경-친화적 세제를 사용한 바이러스 불활성화 방법
DE102015115024A1 (de) * 2015-09-08 2017-03-09 Schülke & Mayr GmbH Flüssigkonzentrat für die Konservierung von Kosmetika
CN109022377A (zh) * 2017-06-12 2018-12-18 舒泰神（北京）生物制药股份有限公司 一种杆状病毒表达系统中杆状病毒的灭活方法
KR102623471B1 (ko) * 2017-07-10 2024-01-09 다케다 야쿠힌 고교 가부시키가이샤 액체를 인큐베이션하고 바이러스를 불활성화시키는 방법
EP3446710A1 (en) * 2017-08-25 2019-02-27 Glenmark Pharmaceuticals S.A. Methods of inactivating viral contaminants
EP3704178B1 (en) * 2017-10-30 2024-07-24 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses
EP3768697A1 (en) 2018-03-21 2021-01-27 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
US20220106573A1 (en) * 2019-03-19 2022-04-07 Amgen Inc. Alternate detergents for viral inactivation
MX2022006987A (es) * 2019-12-12 2022-07-13 Lilly Co Eli Metodos para la inactivacion viral mediante detergentes compatibles con el medioambiente.
WO2021197646A1 (de) * 2020-03-31 2021-10-07 Schülke & Mayr GmbH Wässrige octenidinhaltige zusammensetzung zur behandlung und/oder prävention einer exazerbation von erkrankungen infolge einer coronavirusinfektion
EP4291640A4 (en) * 2021-02-12 2024-08-07 Siemens Healthcare Diagnostics Inc REAGENT COMPOSITIONS FOR SAMPLE LYSIS AND METHODS FOR THEIR PREPARATION AND USE
WO2023052556A1 (en) 2021-09-30 2023-04-06 Ichnos Sciences SA Methods of inactivating viral contaminants with a mixture of solvent and detergent
KR102420201B1 (ko) * 2022-01-17 2022-07-13 주식회사 유이케미칼 인지질 외피 보유 바이러스 사멸기능을 가지는 친환경 방역 조성물
CN116272708B (zh) * 2023-03-16 2023-11-14 海南医学院 一种量子点-抗体复合物微球及其制备方法、应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
EP1740285A4 (en) 2004-04-13 2007-07-04 Sangart Inc METHOD AND COMPOSITIONS FOR SIMULTANEOUS ISOLATION OF HEMOGLOBIN FROM RED BLOOD BODIES AND INACTIVATION OF VIRUSES

Also Published As

Publication number Publication date
KR101921036B1 (ko) 2018-11-21
SG191184A1 (en) 2013-07-31
US20120208982A1 (en) 2012-08-16
AU2011343811A1 (en) 2013-05-09
CA2821971A1 (en) 2012-06-21
CN103370072A (zh) 2013-10-23
CN103370072B (zh) 2016-02-03
KR20180049160A (ko) 2018-05-10
JP2014501247A (ja) 2014-01-20
KR101854310B1 (ko) 2018-05-04
CN105524162A (zh) 2016-04-27
EP2651421A1 (en) 2013-10-23
MX2013006832A (es) 2014-01-31
EA201390856A1 (ru) 2013-12-30
EA025783B1 (ru) 2017-01-30
AU2011343811B2 (en) 2015-04-16
MX352082B (es) 2017-11-08
SG10201509994PA (en) 2016-01-28
AR084301A1 (es) 2013-05-08
JP6013360B2 (ja) 2016-10-25
US20170327559A1 (en) 2017-11-16
MY161252A (en) 2017-04-14
TWI557229B (zh) 2016-11-11
CN105524162B (zh) 2021-04-27
EP3495385A1 (en) 2019-06-12
IL226926B (en) 2020-05-31
WO2012082931A1 (en) 2012-06-21
BR112013015113A2 (pt) 2018-11-06
BR112013015113B1 (pt) 2023-01-31
NZ611994A (en) 2015-04-24
TW201233805A (en) 2012-08-16
KR20130137663A (ko) 2013-12-17

Similar Documents

Publication Publication Date Title
CO6761367A2 (es) Inactivación viral usando un método mejorado de solvente -detergente
EA201690403A1 (ru) Композиции и способы для модулирования рнк
MA41421A (fr) Anticorps humains contre la glycoprotéine du virus ebola
MX2019003525A (es) Moduladores alostericos de proteina nucleo de hepatitis b.
EA201790630A1 (ru) Способы получения рибозидов
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
MA48579A (fr) Anticorps anti-pd1 et méthodes d'utilisation de ceux-ci
MA40938A (fr) Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps
CY1118567T1 (el) Αναστολεις του ιου της ηπατιτιδας c
UY34254A (es) Proteínas y péptidos modificados.
MX2021000435A (es) Moleculas biespecificas que son inmunorreactivas con celulas efectoras inmunes que expresan un receptor activador y un antigeno expresado por una celula infectada por un virus y usos de las mismas.
EP2805442A4 (en) TECHNIQUES FOR GENERATING OUTGOING MESSAGES ON THE BASIS OF LANGUAGE, INTERNATIONALIZATION AND LOCALIZATION PREFERENCES OF THE RECIPIENT
UY34780A (es) Vectores virales para el tratamiento de distrofia retiniana
EA201491224A1 (ru) Анти-псф-тау-антитела и их применение
ECSP15011603A (es) Subunidades de vacunas de inmersión para peces
EA201590384A1 (ru) 6-аминокислота-гетероарилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
EA201690372A1 (ru) Азапиридоновые соединения и их применение
EA201391515A1 (ru) Инактивированная вакцина вируса денге
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
EA201490778A1 (ru) АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ
BR112017006680A2 (pt) variantes de vírus influenza a
IN2014KN02769A (es)
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
CO7240413A2 (es) Composición farmacéutica que comprende fimasartan e hidroclorotiazida